Are the Eagles worried about their offense? What's next for the Titans after firing Brian Callahan? And could the 49ers be ...

Two years ago, Herb Jones looked like one of the most valuable three-and-D weapons in the entire league. In 2023-24, a ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

CLEARWATER, Fla. — Desnee Ebner-Rivers and the word 'cancer' do not get along. Not because she has cancer, but because of what it has taken from her. “I did. I lost all of them," said Ebner-Rivers.

To get the show every day, follow the podcast here. Today's episode of "Markets Daily" begins with a minute of markets updates, followed by an interview with host Jennifer Sanasie and Leo Mizuhara, ...

Are the Eagles worried about their offense? What's next for the Titans after firing Brian Callahan? And could the 49ers be ...